| Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2). | brain, |
| Activation of the c-fos proto-oncogene in the spinal cord following noxious stimulation of the urinary bladder. | bladder, |
| Differential expression of c-fos proto-oncogene in two subclones derived from a human ovarian cancer cell line. | ovarian, |
| Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. | breast, |
| Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers. | pancreatic, |
| Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of G alpha i2. A novel implication of retinoblastoma gene product. | retinoblastoma, |
| Induction of c-fos and c-myc oncogene expression in the pyloric mucosa of rat stomach by N-methyl-N -nitro-N-nitrosoguanidine and taurocholate. | gastric, |
| Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. | lung, |
| Expression of c-fos proto-oncogene mRNA in non-melanoma skin cancer. | skin, |
| Fos oncoprotein expression in the rat forebrain following muscimol-induced absence seizures. | brain, |
| Pituitary adenylate-cyclase-activating polypeptide stimulates proto-oncogene expression and activates the AP-1 (c-Fos/c-Jun) transcription factor in AR4-2J pancreatic carcinoma cells. | pancreatic,pituitary, |
| Brain substrates activated by electroacupuncture of different frequencies (I): Comparative study on the expression of oncogene c-fos and genes coding for three opioid peptides. | brain, |
| Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells. | thyroid, |
| Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas. | endometrial, |
| Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. | brain, |
| Effect of tetrandrine on proto-oncogene c-fos expression in rat cerebrum. | None |
| The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. | None |
| MAP kinase-independent induction of proto-oncogene c-fos mRNA by hemin in human cells. | None |
| Characterisation of developmentally regulated chromatin structure in the coding region of the proto-oncogene, c-fos, in the male laboratory mouse. | None |
| Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene. | None |